2021
DOI: 10.1038/s41416-021-01274-4
|View full text |Cite|
|
Sign up to set email alerts
|

Impact of COVID-19 pandemic on eye cancer care in United Kingdom

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
41
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(48 citation statements)
references
References 7 publications
6
41
0
Order By: Relevance
“…A similar decreasing trend was observed by Baxter et al, who described a nearly 20% reduction in the number of patients receiving the systemic treatment, observed during rst 4 months of the pandemic [4]. The changes described above also apply to the number of patients with other cancers [4,[14][15][16]. So, did we manage to achieve something impossible in our case?…”
Section: Discussionsupporting
confidence: 82%
“…A similar decreasing trend was observed by Baxter et al, who described a nearly 20% reduction in the number of patients receiving the systemic treatment, observed during rst 4 months of the pandemic [4]. The changes described above also apply to the number of patients with other cancers [4,[14][15][16]. So, did we manage to achieve something impossible in our case?…”
Section: Discussionsupporting
confidence: 82%
“…119 COVID-19 pandemic has a hidden impact on eye cancer care as fewer uveal melanoma cases with more advanced diseases were diagnosed during the national lockdowns. 120 (Figure 3).…”
Section: Covid-19 and Ophthalmologymentioning
confidence: 99%
“…While there are multiple reports of orbital involvement in patients with AFS, our case is unique in that there was a significant delay in referral due to the COVID-19 pandemic, which resulted in a poor visual outcome. Unfortunately, delayed presentation and treatment during the pandemic has been reported in the literature both domestically, with emergency department visits for severe ocular injuries, and abroad with ocular oncology and age-related macular degeneration leading to increased morbidity [11][12][13]. As the pandemic continues to evolve, it is imperative to examine referral pathways and barriers to care for all eye-related conditions to prevent future delays in care and associated poor visual outcomes.…”
Section: Discussionmentioning
confidence: 99%